OpenNeedle Ask your own

Question explored with the scientific record

Are there any physical symptoms of Lynch syndrome in children?

Oct 3, 2026 · 3 sources used · OpenNeedle synthesis
Lynch syndrome in children does not cause visible physical symptoms. The condition is a genetic predisposition to cancer, not a disease with a body-wide appearance.

The evidence retrieved focuses on a rare, severe form called constitutional mismatch repair deficiency (CMMRD), where children inherit two faulty copies of a mismatch repair gene. In one study of five Israeli families, affected children developed brain tumors (anaplastic astrocytoma, medulloblastoma) between ages 6 and 17, and colorectal polyps or cancer between ages 14 and 22 [2]. Another report describes two teenagers with CMMRD who had glioblastoma and also carried NF1 mutations, which can produce café-au-lait spots and other skin findings [3]. Those skin marks come from the NF1 gene, not from Lynch syndrome itself.

The key point: a child with Lynch syndrome (one faulty gene copy) looks like any other child. There is no rash, no facial feature, no growth pattern that signals the condition. The PROGRESS study protocol, which aims to disclose genomic results to minors, confirms that the condition is identified through genetic testing, not physical exam [1]. The only "symptoms" are the cancers that may appear later, and in CMMRD those appear in childhood.

My call: Lynch syndrome has no physical symptoms in children. The rare CMMRD form causes childhood cancers, but those are detected by tumor development, not by looking at the child. Confidence: high.

Keep digging

Sources used 3

  1. Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents BMC Pediatrics (2020) Thin

    PROGRESS is a mixed-methods, longitudinal cohort study protocol to determine how disclosing clinically actionable adult- and pediatric-onset genomic variants to minors and their parents affects psychosocial outcomes, cascade testing, and subsequent risk-reduction behaviors, in o…

    DOI: 10.1186/s12887-020-02070-4
  2. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity Pediatric Blood & Cancer (2015) Thin

    This study investigates the prevalence of constitutional mismatch repair deficiency (CMMRD) in Israel, highlighting the significant role of founder mutations and consanguinity in its occurrence among various ethnic groups.

    DOI: 10.1002/pbc.25818
  3. PDCT-02. UNIQUE CONCURRENT ASSOCIATION OF SOMATIC AND GERMLINE NF1 MUTATIONS WITH GERMLINE MISMATCH REPAIR MUTATIONS IN PEDIATRIC GLIOBLASTOMA MULTIFORME Neuro-Oncology (2019) Thin

    Biology-driven DIPG therapy is feasible in a large international trial with everolimus as a potential control arm, while pediatric GBMs with NF1/MMR aberrations highlight the need for integrated germline/somatic molecular testing to guide management.

    DOI: 10.1093/neuonc/noz175.766

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →